Continuous Renal Replacement Therapy Machine Market Report 2024

This Continuous Renal Replacement Therapy Machine market report covers industry characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The continuous renal replacement therapy machine market size has grown strongly in recent years. It will grow from $1.16 billion in 2023 to $1.26 billion in 2024 at a compound annual growth rate (CAGR) of 8.9%. The growth during the historic period can be attributed to the increased prevalence of acute kidney injury, improvements in sepsis management, the aging population, higher hospital admissions, and a rise in chronic kidney disease rates.

The continuous renal replacement therapy machine market size is expected to see strong growth in the next few years. It will grow to $1.78 billion in 2028 at a compound annual growth rate (CAGR) of 9%. The projected growth during the forecast period can be attributed to rising research and clinical trials, the increasing incidence of diabetes, improvements in patient monitoring, expanding education and awareness campaigns, and a growing demand for continuous therapies. Key trends expected in this period include technological advancements, integration of nanotechnology, the use of AI and predictive analytics, high-volume hemofiltration (HVHF), and advancements in ICU machines.

The increasing incidence of acute kidney injury (AKI) is projected to drive the growth of the continuous renal replacement therapy (CRRT) machine market. AKI is characterized by a sudden loss of kidney function, impairing the kidneys' ability to filter waste and regulate fluid and electrolyte balance. This condition can result from decreased blood flow to the kidneys, direct damage from toxins or infections, or urinary tract obstructions. CRRT machines are designed to provide continuous, gentle dialysis, gradually removing waste products and excess fluids from the blood to stabilize the patient's condition and prevent complications. For example, in June 2023, Kidney Research, a UK-based charity, estimated 615,000 cases of AKI in 2022. The number of cases is expected to rise by 4% to 637,000 by 2033. As a result, the growing prevalence of AKI is boosting the demand for CRRT machines.

Leading companies in the CRRT machine market are advancing technologies such as extracorporeal CO2 removal (ECCOR) and therapeutic plasma exchange (TPE) to improve treatment for critically ill patients. ECCOR technology helps in removing toxins and proteins from the blood more effectively, leading to better patient outcomes. For instance, in May 2021, Baxter International, a US-based healthcare company, launched the Baxter PrisMax 2 system. This next-generation platform is designed to enhance CRRT and other organ support therapies in critical care settings. The system aims to simplify complex clinical processes and increase operational efficiency in intensive care units (ICUs). It integrates with Baxter's TrueVue digital health solutions, allowing secure wireless connectivity to electronic medical records (EMR). The PrisMax 2 can provide various therapies, including CRRT, extracorporeal carbon dioxide removal (ECCO₂R) using the PrismaLung+ blood-gas exchanger, and blood purification for managing sepsis.

In December 2021, Baxter International Inc., a US-based medtech company, acquired Hillrom for $12.5 billion. This acquisition highlights Baxter's focus on advancing digital health technologies. Hillrom's expertise in connected care solutions complements Baxter's efforts to enhance patient monitoring and management. The integration of Baxter and Hillrom's capabilities is expected to improve care across multiple settings, from hospitals to home care. Hillrom, a US-based medical device company, provides CRRT machines among other products.

Major companies operating in the continuous renal replacement therapy machine market are Medtronic plc, Fresenius Medical Care AG KGaA, Asahi Kasei Corporation, GE HealthCare Technologies Inc., Toray Industries Inc., Baxter International Inc., Medline Industries LP, Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Nipro Corporation, B. Braun Medical Inc., Shandong Weigao Blood Purification Products Co. Ltd., Nikkiso Co. Ltd., JMS Co. Ltd., NxStage Medical Inc., Kawasumi Laboratories Incorporated, Guangdong Biolight Meditech Co. Ltd., CytoSorbents Corporation, Quanta Dialysis Technologies Ltd., Nuwellis Inc., Medica S.p.A., Anjue Medical Equipment Co. Ltd., Infomed SA, RenalSense Ltd., SWS Hemodialysis Care Co. Ltd.

North America was the largest region in the continuous renal replacement therapy machine market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy machine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the continuous renal replacement therapy machine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Continuous renal replacement therapy (CRRT) machines are specialized medical devices used to deliver continuous, slow, and controlled dialysis treatment to critically ill patients suffering from acute kidney injury (AKI) or severe fluid overload, typically within an intensive care unit (ICU). Unlike traditional dialysis, which is performed intermittently, CRRT operates continuously over 24 hours, offering a gentler approach for patients who are unstable. These machines assist in managing and replacing the filtration function of the kidneys in critically ill patients whose kidneys are compromised due to acute injury or illness.

The continuous renal replacement therapy machine market includes two main types, mobile and fixed. Mobile CRRT machines are designed for easy transport and use across various hospital units. The different modalities offered by these machines include slow continuous ultrafiltration (SCUF), continuous venovenous hemofiltration (CVVH), continuous venovenous hemodialysis (CVVHD), and continuous venovenous hemodiafiltration (CVVHDF). These machines cater to various age groups, including pediatric, adult, and geriatric patients, and are used for applications such as treating acute renal failure, chronic renal failure, and other conditions. End-users of these machines include hospitals, clinics, dialysis centers, home care settings, and more.

The continuous renal replacement therapy machine market research report is one of a series of new reports that provides continuous renal replacement therapy machine market statistics, including the continuous renal replacement therapy machine industry global market size, regional shares, competitors with continuous renal replacement therapy machine market share, detailed continuous renal replacement therapy machine market segments, market trends, and opportunities, and any further data you may need to thrive in the continuous renal replacement therapy machine industry. These continuous renal replacement therapy machine market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The continuous renal replacement therapy machine market consists of sales of blood tubing sets, dialyzers or hemofilters, replacement fluids, anticoagulants, and vascular access catheters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.